ABSTRACT

Biocatalysis is becoming an established method to assist in the manufacture of synthetic targets and, in particular, chiral fine chemicals.

The ability of enzymes (whether isolated or within an intact cell) to cause resolution or synthesis of chiral centers is without precedent, and there is consequently a strong drive to implement such processes in industry.